The DOI matches its Crossref record; 138 of the 139 references it cites were found in a registry or an index.
Oxidative stress in the pathology and treatment of systemic lupus erythematosus
Open accessAbstract
Oxidative stress is increased in systemic lupus erythematosus (SLE), and it contributes to immune system dysregulation, abnormal activation and processing of cell-death signals, autoantibody production and fatal comorbidities. Mitochondrial dysfunction in T cells promotes the release of highly diffusible inflammatory lipid hydroperoxides, which spread oxidative stress to other intracellular organelles and through the bloodstream. Oxidative modification of self antigens triggers autoimmunity, and the degree of such modification of serum proteins shows striking correlation with disease activity and organ damage in SLE. In T cells from patients with SLE and animal models of the disease, glutathione, the main intracellular antioxidant, is depleted and serine/threonine-protein kinase mTOR undergoes redox-dependent activation. In turn, reversal of glutathione depletion by application of its amino acid precursor, N-acetylcysteine, improves disease activity in lupus-prone mice; pilot studies in patients with SLE have yielded positive results that warrant further research. Blocking mTOR activation in T cells could conceivably provide a well-tolerated and inexpensive alternative approach to B-cell blockade and traditional immunosuppressive treatments. Nevertheless, compartmentalized oxidative stress in self-reactive T cells, B cells and phagocytic cells might serve to limit autoimmunity and its inhibition could be detrimental. Antioxidant therapy might also be useful in ameliorating damage caused by other treatments. This Review thus seeks to critically evaluate the complexity of oxidative stress and its relevance to the pathogenesis and treatment of SLE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In various cell types, metabolic aberrations induced by mitochondrial abnormalities are linked to self-reactive and inflammatory phenotypes in autoimmune conditions, including SLE and RA68,69”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [68]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“These events can lead to the generation of neoantigens that could be recognized as exogenous threats by the adaptive immune system68”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [68]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989
Cillà, S. D., Farruggio, S., Vujosevic, S., Raina, G., Filippini, D. A., Gatti, V., Clemente, N., Mary, D., Vezzola, D., Casini, G., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479441 · Cited by 5,154
[1] Role of free radicals and catalytic metal ions in human disease: An overview
Halliwell, B., & Gutteridge, J. M. C. (1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)86093-b · Cited by 4,994
Tsokos, G. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-37754-6.50094-4 · Cited by 3,990
Targeting the KEAP1-NRF2 system to prevent kidney disease progression
Nezu, M., Suzuki, N., & Yamamoto, M. (2017) · American Journal of Nephrology · doi:10.1159/000475890 · Cited by 3,447
Tsokos, G. C. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1100359 · Cited by 2,814
Manzi, S., Meilahn, E. N., Rairie, J. E., Conte, C. G., Medsger, T. A., Jansen-McWilliams, L., D’Agostino, R. B., & Kuller, L. H. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009122 · Cited by 1,831
Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor
Shimazu, T., Hirschey, M. D., Newman, J., He, W., Shirakawa, K., Le Moan, N., Grueter, C. A., Lim, H., Saunders, L. R., Stevens, R. D., et al. (2013) · Science · doi:10.1126/science.1227166 · Cited by 1,777
Chronic Granulomatous Disease: Report on a National Registry of 368 Patients
Winkelstein, J. A., Marino, M. C., Johnston, R. B., Boyle, J., Curnutte, J., Gallin, J. I., Malech, H. L., Holland, S. M., Ochs, H., Quie, P., et al. (2000) · Medicine · doi:10.1097/00005792-200005000-00003 · Cited by 1,728
Casciola-Rosen, L. A., Anhalt, G. J., & Rosen, A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1317 · Cited by 1,723
Flagged first, then by citations
1 of the 139 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Caza, T. N., Talaber, G. & Perl, A. Metabolic regulation of organelle homeostasis in lupus T cells. Clin. Immunol. 144, 200–213 (2012). · DOI
- Dwivedi, J. & Sarkar, P. D. Study of homocysteine, lipoprotein (a), lipid profile with oxidative stress in nephrotic syndrome and lupus nephritis. Res. J. Pharm. Biol. Chem. Sci. 1, 670–679 (2010).
Cited by
Sorted by citations
Items 301–358 of 358
Sikiru, A. B., Arunachalam, A., Egena, S. S. A., Sejian, V., Reddy, I. J., & Bhatta, R. (2020) · doi:10.21203/rs.3.rs-67743/v1 · Cited by 2
Kurien, B. T., Dave, D., Tsaliki, M., Quadri, S. M. S., Lewis, V. M., & Scofield, R. H. (2024) · Clinical & Experimental Immunology · doi:10.1093/cei/uxae114 · Cited by 1
Yamaka, K., Aomura, D., Harada, M., Nakajima, T., Nimura, T., Hashimoto, K., Tanaka, N., & Kamijo, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1571147 · Cited by 1
Glutaredoxin2 reduces age-associated B cell differentiation through maintaining redox homeostasis
Jiang, Y. Y., Sun, C., He, Q., Liu, S., Tian, S., Zhang, Y., Du, Y., Li, F., & Zhang, H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1593816 · Cited by 2
Li, B., Ma, T., Jia, Y., Mou, C., Zeng, M., Yu, J., Zou, L., Li, X., & Wang, H. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101932 · Cited by 1
Iron metabolism and ferroptosis: druggable targets to delay the progression of lupus nephritis
Al-Hraki, L., Morel, L. M., & Scindia, Y. M. (2025) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00229.2025 · Cited by 1
Huang, L., Lin, Q., Li, H., & Shi, J. Y. (2025) · Brain and Behavior · doi:10.1002/brb3.71098 · Cited by 1
Guo, P., Chen, F., & Zhao, M. (2026) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09125-3 · Cited by 1
Żarnowiec, P., Stabrawa, I., Kubala‐Kukuś, A., Banaś, D., Durlik-Popińska, K., Krzemień, A., Terlecki, P., Wudarczyk-Moćko, J., Wąsik, A., Wesołowski, G., et al. (2026) · Spectrochimica Acta Part B Atomic Spectroscopy · doi:10.1016/j.sab.2026.107560 · Cited by 1
Jędreas, A., Michorowska, S., Jan, S. L., Servettaz, A., & Giebułtowicz, J. (2026) · Autoimmunity Reviews · doi:10.1016/j.autrev.2026.104084 · Cited by 1
Zhu, L., Lin, T., Cheong, L. Y., Sher, J. K. H., Yam, I., Cheung, W., Yung, S., Chan, T. M., & Yap, D. Y. H. (2026) · Biomedicines · doi:10.3390/biomedicines14061188 · Cited by 1
Lu, L., Lei, D., Nong, X., Guo, M., Ma, J., & Li, H. (2015) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-015-0131-x · Cited by 1
Twin and family studies on epigenetics of autoimmune diseases
Jokkel, Z., Piroska, M., Szalontai, L., Hernyes, A., Tárnoki, D. L., & Tárnoki, Á. D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820951-6.00009-0 · Cited by 1
A global view of T cell metabolism in Systematic Lupus ErythematosusPreprint
Goetz, A., Morel, L. M., & Dixit, P. D. (2024) · ChemRxiv · doi:10.26434/chemrxiv-2024-00hdq · Cited by 1
T Cell Targeted Therapies in Lupus: Do They Make Sense?
Thanou, A., & Merrill, J. T. (2015) · Current Treatment Options in Rheumatology · doi:10.1007/s40674-014-0008-x
Epigenetics of Rheumatic Diseases
Sawalha, A. H. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-31696-5.00022-x
Oxidative Stress in Systemic Lupus Erythematosus
Perl, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801917-7.00028-0
Self-citationPanousis, N. I., Bertsias, G. K., Ongen, H., Gergianaki, I., Tektonidou, M. G., Trachana, M., Romano, L., Bielser, D., Howald, C., Pamfil, C. A. M., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/255109
Oates, J. C., & Nowling, T. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47927-1.00018-9
Pharmacoepigenetics of Rheumatic Disorders
Castro, P. G., & Díaz‐Peña, R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813939-4.00020-6
Perl, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814551-7.00031-3
Self-citationRackov, G., Zaniani, P. T., Colomo, S., Shokri, R., Álvarez‐Mon, M., Martínez‐A, C., & Balomenos, D. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.19.427239
Chan, T. M., & Yung, S. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732868595.793576806
Antioxidant Status of Serum Bilirubin, Uric Acid and Albumin in Pemphigus Vulgaris
Ain, Q., Saeed, W., Khan, F. N., Imtiaz, A., Niazi, N., & Mansoor, M. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs22167208
Blagov, A. V., Zhuravlev, A. D., Sukhorukov, V. N., Popov, M. A., Grechko, A. V., & Orekhov, A. N. (2023) · European Journal of Inflammation · doi:10.1177/1721727x231194240
Formas de tratamento do Lúpus eritematoso sistêmico: uma revisão de literatura
de Paiva, M. J. M., Cubas, A. M., Júnior, C. A. P., Almeida, C. M. D. L., Feitosa, I. C., Silva, L. T. D., & dos Santos, T. T. (2024) · Cuadernos de Educación y Desarrollo · doi:10.55905/cuadv16n1-163
Nowling, T. K., & Oates, J. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-93232-5.00028-9
Metabolic control of immunopathogenesis in systemic lupus erythematosus
Perl, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-93232-5.00023-x
Self-citationBilodeau, P., & Tselios, K. (2025) · Frontiers in Lupus · doi:10.3389/flupu.2025.1607792
Hasan, S. Y., Yasir, S. J., Al.Janabi, A., & Mohsen, Z. A. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5337872
Liu, L., Henning, S., van Goor, H., Bootsma, H., der Meer, B. D., Westra, J., & de Leeuw, K. (2026) · Antioxidants · doi:10.3390/antiox15080995
Sayed, N. E., Halwag, D. I., Helaly, N. A., & Abdelmeniem, I. M. (2025) · Dermatology Practical & Conceptual · doi:10.5826/dpc.1503a5346
Chronic inflammatory disorders and their redox control reaction
Duttaroy, A. K., & Jena, A. B. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-43884-4.00011-8
Inhibition of DJ-1 protects from lupus onset and severity
Jiang, M., Wang, M., Wan, L., Li, S., Sun, C., Cao, H., Yu, C., & Lin, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-15670-w
Emelyanova, O. I., Trofimenko, A. S., & Русанова, О. А. (2025) · Proceedings of the National Academy of Sciences of Belarus Medical series · doi:10.29235/1814-6023-2025-22-3-232-238
Catalytic IgG Antibodies Hydrolyze DNA, Histones, and HMGB1 in Systemic Lupus Erythematosus
Melamud, M. M., Ermakov, E. A., Tolmacheva, A. S., Kostrikina, I. A., Сизиков, А. Э., Nevinsky, G. A., & Buneva, V. N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199635
Liu, D.-Y., Chung, C., Wang, Y.-T., Lee, H., Cheng, T.-A., Lin, C.-A., Su, Y., Yao, P.-T., Shen, T., Lin, H.-J., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-101079
Wani, Z. A., Nazir, S., Nasir, A., Iqbal, A., & Bihari, C. (2025) · Cureus · doi:10.7759/cureus.96374
Wang, J., Jiang, Z., Zhang, G., Liu, Z., Cai, J., & Zheng, P. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01948-w
Schmitt, F. C., Nguyen, S. T., Claßen, P. C., Meineck, M., Hagen, M., Weinmann‐Menke, J., & Schmidlin, T. (2025) · Metabolites · doi:10.3390/metabo15110738
Melatonin: Diagnostic evidence and therapeutic roles in systemic lupus erythematosus
Hosseinzadeh, A., Seirafianpour, F., Sheibani, M., Naeini, A. J., Reiter, R. J., & Mehrzadi, S. (2025) · Current Molecular Pharmacology · doi:10.1016/j.cmp.2025.11.001
Fatemi, A., Alipour, R., Khanahmad, H., Alsahebfosul, F., Andalib, A., & Pourazar, A. (2021) · Figshare · doi:10.6084/m9.figshare.13725308
Fatemi, A., Alipour, R., Khanahmad, H., Alsahebfosul, F., Andalib, A., & Pourazar, A. (2021) · Figshare · doi:10.6084/m9.figshare.13725314
Kitai, H., Kato, N., Ogami, K., Komatsu, S., Watanabe, Y., Yoshino, S., Koshi-Ito, E., Tsubota, S., Funahashi, Y., Maeda, T., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21541956
Glutaminase-mediated glutamate metabolism is critical for maintaining Th17/Treg balance
Jin, X., & Tao, J. (2025) · Central European Journal of Immunology · doi:10.5114/ceji.2025.155429
Li, J., Gan, H., Zhong, Y., & Liu, H. (2026) · Molecular Genetics and Genomics · doi:10.1007/s00438-026-02441-z
Jiang, M., Zhang, F., Ren, M., Li, Z., Xie, Z., & Sun, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1841513
Immunometabolism of systemic lupus erythematosus
Furment, M. M., & Perl, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33957-8.00042-1
Self-citationNucleotide Metabolism in Health and Disease
Zhao, X., Zeng, Y., Xu, Y., Rao, S., Khouchani, M., Soummane, H., Li, J., & Liu, R. (2026) · MedComm · doi:10.1002/mco2.70900
Zhou, X., Jiang, Y., Xu, S., & Shan, N. (2026) · Autoimmunity Reviews · doi:10.1016/j.autrev.2026.104168
Immunometabolism and rheumatic disease—advancing targeted therapies
Boothby, M. R. (2026) · EULAR Rheumatology Open · doi:10.1016/j.ero.2026.100235
T Cells in Systemic Lupus Erythematosus: Biology and Clinical Value
Simon, R., Pan, W., & Tsokos, G. C. (2026) · Arthritis & Rheumatology · doi:10.1002/art.70355
Viana, M. D. M., Pereira, D. D., Santos, S. S., Calderari, M. L. C., da da Silva, V. E. F., Lins, M. P., & Silva, L. H. A. C. (2026) · Antioxidants · doi:10.3390/antiox15101288
Mitochondria: a protector or culprit in lupus?
Perl, A., & Morel, L. M. (2026) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2026.2747220
Self-citationNRF2: sensing stress, shaping immunity - keeping inflammation quiet and antigens out of sight
Benatzy, Y., & Brüne, B. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1974746
Metabolic gatekeepers shape immune cell function in rheumatoid arthritis
Jia, L., Kothagundla, M. N., Goronzy, J. J., & Weyand, C. M. (2026) · Clinical Science · doi:10.1042/cs20250834
Saeed, L. M., Naji, S. A., Yousif, R. M., Alasmari, M. M., Alshaeri, H. K., Junaidi, H. S. A., Makai, A., Talib, W. H., & Hock, M. (2026) · Scientific Reports · doi:10.1038/s41598-026-67917-9
Metadata
- Authors
- Perl, A.
- Venue
- Nature Reviews Rheumatology
- Published
- 2013-10-08
- Volume
- 9
- Issue
- 11
- Pages
- 674-686
- ISSN
- 1759-4790 (ISSN-L)
- 1759-4804
- PMC
- PMC4046645
- OpenAlex
- W2078472057
- Cited by
- 358
- References
- 139
- Citations by year
- 2026: 18 · 2025: 44 · 2024: 36 · 2023: 18 · 2022: 28 · 2021: 32 · 2020: 36 · 2019: 27 · 2018: 25 · 2017: 19 · 2016: 33 · 2015: 28 · 2014: 14
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Reviews Rheumatology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R01AI048079, R01AI072648, AI 048, AI 072)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (U01AR076092)
- National Center for Complementary and Integrative Health (AT-004332, R01AT004332)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- oxidative stress, systemic lupus erythematosus, mitochondrial dysfunction, T cells, lipid hydroperoxides, glutathione depletion, mTOR, N-acetylcysteine, antioxidant therapy, autoimmunity, autoantibody production, disease activity, organ damage, lupus-prone mice
- MeSH terms
- Animals, Antioxidants, Humans, Lupus Erythematosus, Systemic, Autoimmunity, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
